Prestige Consumer Healthcare Inc. Announces New $25 Million Share Repurchase Program, Participation in the Raymond James Institutional Investors Conference
02 mars 2020 06h30 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., March 02, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that the Company’s Board of Directors authorized the repurchase of up to $25.0...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Third Quarter and Year-to-Date Results
06 févr. 2020 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue $241.6 Million in Q3 Fiscal 2020; Organic Revenue up 0.5% versus Prior Year Q3GAAP Diluted EPS of $0.75 in Q3 Fiscal 2020; Adjusted EPS of $0.81, Up 11% Versus Prior Year Q3Year-to-date Cash...
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Third Quarter Earnings Results
06 janv. 2020 18h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 third quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Announces Pricing of $400 Million Senior Notes
15 nov. 2019 16h15 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...
Prestige Consumer Healthcare Inc. Announces Offering of $400 Million Senior Notes
15 nov. 2019 07h35 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Nov. 15, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE: PBH) (the “Company”) announced today that its wholly-owned subsidiary, Prestige Brands, Inc. (“Prestige...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Second Quarter and Year-to-Date Results
31 oct. 2019 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue $238.1 Million in Q2 Fiscal 2020; Organic Revenue FlatGAAP Diluted EPS of $0.65 in Q2 Fiscal 2020; Adjusted EPS of $0.68, Up 5% Versus Prior Year Q2Cash Flow From Operations of $50.2 Million;...
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 Second Quarter Earnings Results
02 oct. 2019 18h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., Oct. 02, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 second quarter earnings release on Thursday,...
Prestige Consumer Healthcare Inc. Reports Fiscal 2020 First Quarter Results
01 août 2019 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue $232.2 Million in Q1 Fiscal 2020; Organic Revenue Flat as ExpectedEPS of $0.65 in Q1 Fiscal 2020Cash Flow From Operations of $52.8 Million in Q1; Non-GAAP Free Cash Flow of $50.8...
Prestige Consumer Healthcare Inc. to Release Fiscal 2020 First Quarter Earnings Results
08 juil. 2019 17h00 HE
|
Prestige Consumer Healthcare Inc.
TARRYTOWN, N.Y., July 08, 2019 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2020 first quarter earnings release on Thursday, August...
Prestige Consumer Healthcare Inc. Reports Fiscal 2019 Fourth Quarter and Full-Year Results
09 mai 2019 06h00 HE
|
Prestige Consumer Healthcare Inc.
Revenue was $241.0 Million in Q4 and $975.8 Million in Full-Year Fiscal 2019Organic Revenue Grew 3.2% in Q4 and 0.1% in Fiscal 2019Reduced Debt by $200 Million and Repurchased $50 Million of Shares in...